Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease (NCT06655493) | Clinical Trial Compass
CompletedNot Applicable
Levels of Inflammation in Middle East People With Cardiovascular Disease With/Without Kidney Disease
Saudi Arabia, United Arab Emirates756 participantsStarted 2024-11-22
Plain-language summary
This study will collect medical and background information from participants with diseases that affect the heart and blood vessels (cardiovascular disease) with/without kidney disease.
The aim of the study is to assess the number of people with high levels of systemic inflammation among Middle East people with cardiovascular with/without kidney disease. Systemic inflammation means that it occurs throughout the body.
Participation in this study only requires a single visit at the clinic/hospital/medical institution. Participants will continue their normal care and will not get any treatment as part of this study.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
. Male or female, age above or equal to 18 years at the time of signing informed consent.
. Diagnosed with ASCVD+CKD and/or HF (pEF or mrEF)
Exclusion criteria
. Previous participation in this study. Participation is defined as having given informed consent in this study.
. Current participation (i.e., signed informed consent) in any other interventional clinical study.
. Any hospitalization or unplanned visit within the last 60 days (including exacerbation of chronic disease with hospitalization).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study specifically looked at inflammation levels using hsCRP in Middle Eastern patients with cardiovascular disease — how does my own hsCRP level compare to the threshold of 2 mg/L they used, and what does that mean for my personal risk?
2Since this trial has already been completed, have the results been published yet, and is there anything in the findings about people who have both cardiovascular disease and kidney disease that might be relevant to my situation?
3This was an observational study measuring inflammation rather than testing a treatment — based on what this research found, would you recommend any changes to how we monitor or manage my inflammation going forward?
4Given that this study focused on Middle Eastern populations specifically, do you think its findings on hsCRP and cardiovascular disease apply to me, and are there other studies I should also be aware of that might be more directly relevant to my background?
5If my hsCRP turns out to be elevated like the patients in this study, what are the actual treatment options we should be discussing to address that inflammation alongside my cardiovascular care?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
High Sensitivity C-Reactive Protein (hsCRP) ≥2 mg/L